Article
Teva Pharm bets on neurology drugs for growth as Q1 profit misses
Rating:
0.0
Views:
44
Likes:
1
Library:
1
Teva Pharmaceutical Industries , the world's largest generic drugmaker, is looking to a trio of branded drugs to drive future growth, as a bad miss in first-quarter profit sent its shares tumbling.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value